284 related articles for article (PubMed ID: 12792175)
1. Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke.
Tanne D; Haim M; Boyko V; Goldbourt U; Reshef T; Adler Y; Brunner D; Mekori YA; Behar S
Cerebrovasc Dis; 2003; 16(2):166-70. PubMed ID: 12792175
[TBL] [Abstract][Full Text] [Related]
2. Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke.
Elkind MS; Tondella ML; Feikin DR; Fields BS; Homma S; Di Tullio MR
Stroke; 2006 Mar; 37(3):790-5. PubMed ID: 16424371
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of anti-Chlamydia pneumoniae IgA and IgG antibodies in young adults with ischemic stroke.
Piechowski-Jóźwiak B; Mickielewicz A; Gaciong Z; Berent H; Kwieciński H
Acta Neurol Scand; 2007 Sep; 116(3):144-9. PubMed ID: 17714326
[TBL] [Abstract][Full Text] [Related]
4. Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients.
Wolf SC; Mayer O; Jürgens S; Vonthein R; Schultze G; Risler T; Brehm BR
Clin Nephrol; 2003 Apr; 59(4):273-9. PubMed ID: 12708567
[TBL] [Abstract][Full Text] [Related]
5. Infections and Chlamydia pneumoniae antibodies influence the functional outcome in thrombolysed strokes.
Consoli D; Vidale S; Arnaboldi M; Cavallini A; Consoli A; Galati F; Guidetti D; Micieli G; Rasura M; Sterzi R; Toni D; Inzitari D
J Neurol Sci; 2017 Oct; 381():95-99. PubMed ID: 28991723
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial.
Hilden J; Lind I; Kolmos HJ; Als-Nielsen B; Damgaard M; Hansen JF; Hansen S; Helø OH; Hildebrandt P; Jensen GB; Kastrup J; Kjøller E; Nielsen H; Petersen L; Jespersen CM; Gluud C;
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):385-92. PubMed ID: 20226329
[TBL] [Abstract][Full Text] [Related]
7. Chlamydia pneumoniae in elderly patients with stroke (C-PEPS): a case-control study on the seroprevalence of Chlamydia pneumoniae in elderly patients with acute cerebrovascular disease.
Ngeh J; Gupta S; Goodbourn C; Panayiotou B; McElligott G
Cerebrovasc Dis; 2003; 15(1-2):11-6. PubMed ID: 12499705
[TBL] [Abstract][Full Text] [Related]
8. The relationship between seropositivity against Chlamydia pneumoniae and stroke and its subtypes in a Latvian population.
Kēniņa V; Auce P; Millers A
Medicina (Kaunas); 2011; 47(12):657-60. PubMed ID: 22370464
[TBL] [Abstract][Full Text] [Related]
9. Association of Chlamydia pneumoniae serology and ischemic stroke.
Hasan ZN
South Med J; 2011 May; 104(5):319-21. PubMed ID: 21606708
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia pneumoniae seropositivity in aetiological subtypes of brain infarction and carotid atherosclerosis: a case control study.
Alamowitch S; Labreuche J; Touboul PJ; Eb F; Amarenco P;
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):147-51. PubMed ID: 17911183
[TBL] [Abstract][Full Text] [Related]
11. Chlamydia pneumoniae seropositivity is associated with increased plasma levels of soluble cellular adhesion molecules in community-dwelling subjects: the Shimanami Health Promoting Program (J-SHIPP) study.
Kohara K; Tabara Y; Yamamoto Y; Igase M; Miki T
Stroke; 2002 Jun; 33(6):1474-9. PubMed ID: 12052977
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia pneumoniae and future risk in patients with coronary heart disease.
Haim M; Tanne D; Battler A; Boyko V; Reshef T; Goldbourt U; Brunner D; Mekori YA; Behar S;
Int J Cardiol; 2004 Jan; 93(1):25-30. PubMed ID: 14729431
[TBL] [Abstract][Full Text] [Related]
13. Chlamydia pneumoniae infection and risk for lung cancer.
Chaturvedi AK; Gaydos CA; Agreda P; Holden JP; Chatterjee N; Goedert JJ; Caporaso NE; Engels EA
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1498-505. PubMed ID: 20501758
[TBL] [Abstract][Full Text] [Related]
14. Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study.
Elkind MS; Lin IF; Grayston JT; Sacco RL
Stroke; 2000 Jul; 31(7):1521-5. PubMed ID: 10884447
[TBL] [Abstract][Full Text] [Related]
15. Association between Chlamydia pneumoniae and acute myocardial infarction in young men in the United States military: the importance of timing of exposure measurement.
Arcari CM; Gaydos CA; Nieto FJ; Krauss M; Nelson KE
Clin Infect Dis; 2005 Apr; 40(8):1123-30. PubMed ID: 15791511
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis.
Coles KA; Plant AJ; Riley TV; Smith DW; McQuillan BM; Thompson PL
Am J Cardiol; 1999 Oct; 84(7):825-8. PubMed ID: 10513782
[TBL] [Abstract][Full Text] [Related]
17. Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes.
Wong BY; Gnarpe J; Teo KK; Ohman EM; Prosser C; Gibler WB; Langer A; Chang WC; Armstrong PW
Am Heart J; 2002 Dec; 144(6):987-94. PubMed ID: 12486422
[TBL] [Abstract][Full Text] [Related]
18. [Chlamydia antibody titers in patients with coronary disease: relations to age and clinical stage].
el-Rabadi K; Gottsauner-Wolf M; Christ G; Maurer G; Huber K
Wien Klin Wochenschr; 2001 Oct; 113(19):727-30. PubMed ID: 11715750
[TBL] [Abstract][Full Text] [Related]
19. Association between Chlamydophila pneumoniae infection and risk of coronary heart disease for Japanese: the JPHC study.
Sakurai-Komada N; Iso H; Koike KA; Ikeda A; Umesawa M; Ikehara S; Inoue M; Tsugane S
Atherosclerosis; 2014 Apr; 233(2):338-342. PubMed ID: 24530959
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of chlamydia pneumoniae antibodies in patients with coronary heart disease].
Podsiadły E; Kruk M; Przyłuski J; Deptuch T; Ruzyłło W; Tylewska-Wierzbanowska S
Przegl Epidemiol; 2001; 55(3):253-60. PubMed ID: 11761832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
